Hogy Medical Co Ltd

Chart & Performance

D1W1MN

P/E

36.91

P/S

2.65

EPS

130.06

Div Yield, %

1.83%

Shrs. gr., 5y

-4.45%

Rev. gr., 5y

1.30%

Revenues

39.10b

+0.31%

Net income

2.80b

-35.03%

CFO

7.12b

-22.44%

Dividend

Mar 28, 20250 JPY/sh

Profile

Hogy Medical Co.,Ltd., together with its subsidiaries, manufactures and sells medical supplies to healthcare facilities in Japan. It offers kit products for surgery applications; all-in-one kits for pre/mid/post-surgery; non-woven products, including gowns, personal protective equipment and wearables, drapes, packaged products, instrument table covers, and wraps; and Tigalyer, a multi-layer fabric. The company also provides sterilization products, such as hybrid Mekkin bags, hybrid Mekkin bags ID layered type, and autoclave forceps stand caps; Mekkin cards, which are detection cards used to judge the sterilization process when sterilizing in an autoclave; ethylene oxide gas cards that are detection cards used to judge the sterilization process when sterilizing using ethylene oxide gas; and indicator tapes for autoclave sterilization. In addition, it offers ME equipment operation management system; narcotics/poisons box, an automatic drug reading management system using radio frequency identification; and Securea, a polyurethane sponge for endoscopic surgery. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co.,Ltd. in 1987. Hogy Medical Co.,Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.

URL

http://www.hogy.co.jp/

IPO date

Dec 04, 1991

Employees

1,441

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03	2015‑03
Income
Revenues	39,100,000 0.31%	38,981,000 5.99%	36,778,000 0.75%
Cost of revenue	35,228,000	32,056,000	30,281,000
Unusual Expense (Income)
NOPBT	3,872,000	6,925,000	6,497,000
NOPBT Margin	9.90%	17.77%	17.67%
Operating Taxes	1,282,000	1,904,000	1,951,000
Tax Rate	33.11%	27.49%	30.03%
NOPAT	2,590,000	5,021,000	4,546,000
Net income	2,804,000 -35.03%	4,316,000 -1.24%	4,370,000 -11.88%
Dividends	(1,892,000)	(1,697,000)	(1,995,000)
Dividend yield	2.08%	2.20%	2.16%
Proceeds from repurchase of equity			(18,656,000)
BB yield			20.16%
Debt
Debt current	2,154,000	3,222,000	2,336,000
Long-term debt	3,669,000	5,668,000	7,667,000
Deferred revenue		456,000	510,000
Other long-term liabilities	1,071,000	698,000	521,000
Net debt	(22,809,000)	(19,276,000)	(13,538,000)
Cash flow
Cash from operating activities	7,117,000	9,176,000	8,501,000
CAPEX	(2,686,000)	(1,392,000)	(3,201,000)
Cash from investing activities	(3,262,000)	(1,951,000)	(3,812,000)
Cash from financing activities	(3,892,000)	(3,142,000)	(11,049,000)
FCF	4,328,000	6,623,000	4,180,000
Balance
Cash	19,419,000	18,862,000	14,364,000
Long term investments	9,213,000	9,304,000	9,177,000
Excess cash	26,677,000	26,216,950	21,702,100
Stockholders' equity	81,041,000	181,943,000	175,640,000
Invested Capital	66,335,000	66,291,050	68,345,900
ROIC	3.91%	7.46%	6.67%
ROCE	4.12%	7.44%	7.14%
EV
Common stock shares outstanding	24,268	24,257	28,564
Price	3,750.00 18.11%	3,175.00 -2.01%	3,240.00 -4.00%
Market cap	91,005,150 18.16%	77,016,051 -16.78%	92,546,041 -9.30%
EV	68,204,150	136,787,051	155,466,041
EBITDA	10,479,000	10,542,000	10,612,000
EV/EBITDA	6.51	12.98	14.65
Interest	23,000	29,000	6,000
Interest/NOPBT	0.59%	0.42%	0.09%